Contemporary Management of HIV: New Data From IDWeek 2019

Join us for an engaging discussion with 2 leading experts who will explore the implications of new HIV data presented at IDWeek 2019 for your patient care strategies.

Agenda

  • Introduction and Program Overview
  • Key Findings From IDWeek 2019
  • Question and Answer Session

Events

Date / Time
Event Details
12/3/2019
6:00 PM
12/3/2019
6:00 PM
12/4/2019
6:00 PM

Contemporary Management of HIV: New Data From IDWeek 2019

Chicago, IL
Morton’s The Steakhouse - Chicago Details
12/4/2019
6:00 PM
12/4/2019
6:00 PM

Contemporary Management of HIV: New Data From IDWeek 2019

San Francisco, California
Morton’s The Steakhouse - San Francisco Details

Faculty

Program Director
Joseph Eron, MD

Professor of Medicine and Epidemiology
University of North Carolina School of Medicine
Director, AIDS Clinical Trials Unit
University of North Carolina
Chapel Hill, North Carolina

Program Director
Princy Kumar, MD

Professor of Medicine and Microbiology
Chief,
Division of Infectious Diseases and Travel Medicine
Senior Associate Dean of Students
Georgetown University School of Medicine
Washington, DC

Faculty
Roger Bedimo, MD

Professor of Medicine
Division of Infectious Diseases
University of Texas Southwestern Medical Center
Section Chief
Division of Infectious Diseases
Department of Internal Medicine
VA North Texas Health Care System
Dallas, Texas

Faculty
Eric Daar, MD

Chief, Division of HIV Medicine
Harbor-UCLA Medical Center
Professor of Medicine
David Geffen School of Medicine at UCLA
Los Angeles, California

Faculty
Monica Ghandi, MD

Professor of Medicine
Division of HIV, Infectious Diseases, and Global Medicine
University of California, San Francisco
Medical Director
Ward 86 HIV Clinic
San Francisco General Hospital
San Francisco, California

Faculty
David Hardy, MD

Adjunct Professor of Medicine
Division of Infectious Diseases
Johns Hopkins University School of Medicine
Washington, DC

Faculty
William Short, MD

Associate Professor of Medicine
Division of Infectious Diseases
Department of Medicine
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania

Faculty
Babafemi Taiwo, MBBS

Gene Stollerman Professor of Medicine
Chief,
Division of Infectious Diseases
Northwestern University Feinberg School of Medicine
Chicago, Illinois

Faculty
Timothy Wilkin, MD

Associate Professor of Medicine
Co-Director, Cornell Clinical Trials Unit
Weill Cornell Medical College
New York, New York

Goal Statement
The goal of this activity is to improve participants’ competence in providing optimal care for HIV-infected patients through the appropriate use of contemporary ARV regimens.

Target Audience 
This program is intended for physicians, registered nurses, physician assistants, pharmacists, and other healthcare professionals who provide care for HIV-infected patients.

Learning Objectives 

  • Integrate best practices when selecting first-line ARV regimens for HIV-infected patients
  • Apply appropriate treatment modification strategies for patients already receiving ART including those who are virologically suppressed and those with virologic failure
  • Incorporate data on evolving treatment paradigms into the individualized care of HIV-infected patients, as appropriate

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Credit Designation

CCO designates this live activity for a maximum of 2.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 2.5 contact hours.

Pharmacist Continuing Education
CCO designates this continuing education activity for 2.5 contact hours (0.25 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - JA4008176-0000-19-008-L02-P.

Type of Activity: Application

Disclosure of Conflicts of Interest 
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.